摘要 |
The present invention relates to pharmaceutical compositions and more particula to apharmaceutical composition containing the compound {1S-[la, 2a,311(1S*,2R*),511]).-3- -{[2-(3,4- difluorophenypcyclopropyllamino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-y -(2- hydroxyethoxy)cyclopentane-1,2-diol.No suitable figure. 13 AbstractCOMPOSITIONS, SUITABLE FOR ORAL ADMINISTRATION, COMPRISING A TRIAZOLO [4, 5-DWYRIMIDIN DERIVATEThe present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing the compound {1S-Ela, 2a,311(1S*,2R1,5BD-3-(7-([2-(3,4- ditluorophenypcyclopropyljamino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-dlpyrimidin-3-y1)-5-(2- hydroxyethoxy)cyclopentane-1,2-diol.No suitable figure. |